Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anavex Life Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 10
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Anavex Life Sciences Enters into Partnership with Ariana Pharmaceuticals 12
Anavex Enters Into Agreement With Roskamp Institute To Develop ANAVEX PLUS 13
Licensing Agreements 14
Anavex Enters Into Licensing Agreement With Life Science Research Israel 14
Equity Offering 15
Anavex Life Sciences Plans to Raise up to USD50 Million in Public Offering of Shares 15
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD29 Million 16
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD100 Million 17
Anavex Life Sciences to Raise USD0.5 Million in Private Placement of Shares and Warrants 18
Anavex Life Sciences Announces Private Placement Of Units For US$2.6 Million 19
Anavex Life Sciences Completes First Tranche Of Private Placement Of Shares For US$0.1 Million 20
Debt Offering 21
Anavex Life Sciences Completes Private Placement Of Debenture For US$10 Million 21
Anavex Life Sciences Corp – Key Competitors 22
Anavex Life Sciences Corp – Key Employees 23
Anavex Life Sciences Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 09, 2018: Anavex Life Sciences reports fiscal third quarter 2018 financial results 25
May 10, 2018: Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results 26
Feb 07, 2018: Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results 27
Dec 11, 2017: Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs 28
Aug 07, 2017: Anavex Reports Fiscal Third Quarter 2017 Financial Results 29
May 10, 2017: Anavex Reports Fiscal Second Quarter 2017 Financial Results 31
Feb 07, 2017: Anavex Reports Fiscal First Quarter 2017 Financial Results 32
Corporate Communications 33
Mar 05, 2018: Anavex Life Sciences Announces Management Changes 33
Jul 20, 2017: Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board 34
Jul 20, 2017: Anavex Life Sciences appoints scientific advisory board member 35
May 01, 2017: Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs 36
Feb 13, 2017: Anavex Life Sciences Strengthens Board of Directors 37
Legal and Regulatory 38
Mar 30, 2017: Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit 38
Jan 03, 2017: Anavex Life Sciences Obtains Permanent Dismissal of All Claims in Securities Lawsuit 39
Product News 40
Nov 21, 2017: Anavex Life Sciences Reports Newly Published Data on Alzheimer’s Disease Research Demonstrate the Neuroprotective Features of the Sigma-1 Receptor 40
08/29/2018: Anavex enrols first patient in Phase llb/lll trial of ANAVEX2-73 41
07/20/2017: Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board 42
07/04/2018: Anavex secures approval to start Phase llb/lll trial of ANAVEX 2-73 43
Clinical Trials 44
Jul 25, 2018: Anavex Life Sciences presents new data identifying treatment response biomarkers in Alzheimer’s Disease patients treated with investigational ANAVEX2-73 at 2018 Alzheimer’s Association International Conference 44
Jul 09, 2018: Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX 2-73 for the Treatment of Parkinson’s Disease Dementia 46
Apr 17, 2018: Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX2-73 in Parkinson’s Disease Dementia and Provides Clinical Study Update for ANAVEX2-73 in Rett Syndrome 47
Mar 07, 2018: Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) 48
Jan 16, 2018: Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX2-73 Published in The Journal of Clinical Hypertension 49
Nov 04, 2017: Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX2-73 at 2017 Clinical Trials on Alzheimer’s Disease Meeting 50
Oct 30, 2017: Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Conference 52
Oct 27, 2017: Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017 53
Oct 12, 2017: Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX2-73 in Mild-to-Moderate Alzheimer’s Disease Patients 54
May 22, 2017: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome-Data Presented at Antiepileptic Drug Trials XIV 2017 Conference 55
Jan 19, 2017: Anavex Life Sciences Receives Grant From Rettsyndrome.org to Commence U.S. Phase 2 Trial in 2017 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anavex Life Sciences Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Anavex Life Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 10
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Anavex Life Sciences Enters into Partnership with Ariana Pharmaceuticals 12
Anavex Enters Into Agreement With Roskamp Institute To Develop ANAVEX PLUS 13
Anavex Enters Into Licensing Agreement With Life Science Research Israel 14
Anavex Life Sciences Plans to Raise up to USD50 Million in Public Offering of Shares 15
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD29 Million 16
Anavex Life Sciences Files Registration Statement for Public Offering of Shares for up to USD100 Million 17
Anavex Life Sciences to Raise USD0.5 Million in Private Placement of Shares and Warrants 18
Anavex Life Sciences Announces Private Placement Of Units For US$2.6 Million 19
Anavex Life Sciences Completes First Tranche Of Private Placement Of Shares For US$0.1 Million 20
Anavex Life Sciences Completes Private Placement Of Debenture For US$10 Million 21
Anavex Life Sciences Corp, Key Competitors 22
Anavex Life Sciences Corp, Key Employees 23
Anavex Life Sciences Corp, Subsidiaries 24
List of Figures
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Anavex Life Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Anavex Life Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 10